JW Leatherman, WL Fluegel, WS David, SF Davies and C Iber
Department of Medicine, Hennepin County Medical Center, Minneapolis, Minnesota.

Patients who undergo mechanical ventilation for severe asthma are at risk of developing diffuse muscle weakness because of acute myopathy. The relative importance of corticosteroids and neuromuscular paralysis in causing the myopathy is controversial, and it is uncertain whether the chemical structure of the drug used to induce paralysis influences the risk of myopathy. Using a retrospective cohort study design, we evaluated 107 consecutive episodes of mechanical ventilation for severe asthma to assess (1) the incidence of clinically significant weakness in patients treated with corticosteroids alone versus corticosteroids with neuromuscular paralysis, (2) the influence of the duration of paralysis on the incidence of muscle weakness, and (3) the relative risk of weakness in patients paralyzed with the nonsteroidal drug atracurium versus an aminosteroid paralytic agent (pancuronium, vecuronium). The use of corticosteroids and a neuromuscular blocking agent was associated with a much higher incidence of muscle weakness as compared with the use of corticosteroids alone (20 of 69 versus O of 38, p < 0.001). The 20 weak patients were paralyzed significantly longer than the 49 patients who received a neuromuscular blocking agent without subsequent weakness (3.4 +/- 2.4 versus 0.6 +/- 0.7 d, p < 0.001). Eighteen of the 20 weak patients had been paralyzed for more than 24 h. The incidence of weakness was not reduced when paralysis was achieved with atracurium as opposed to an aminosteroid neuromuscular blocking agent. In conclusion, corticosteroid-treated patients with severe asthma who undergo prolonged neuromuscular paralysis are at significant risk for the development of muscle weakness, and the risk of weakness is not reduced by use of atracurium.

This article has been cited by other articles:

				W. D. Schweickert and J. Hall ICU-Acquired Weakness Chest, May 1, 2007; 131(5): 1541 - 1549. [Abstract] [Full Text] [PDF]

				G. Hermans, A. Wilmer, W. Meersseman, I. Milants, P. J. Wouters, H. Bobbaers, F. Bruyninckx, and G. Van den Berghe Impact of Intensive Insulin Therapy on Neuromuscular Complications and Ventilator Dependency in the Medical Intensive Care Unit Am. J. Respir. Crit. Care Med., March 1, 2007; 175(5): 480 - 489. [Abstract] [Full Text] [PDF]

				M. M. Levy, M. S. Baylor, G. R. Bernard, R. Fowler, T. J. Franks, F. G. Hayden, R. Helfand, S. E. Lapinsky, T. R. Martin, M. S. Niederman, et al. Clinical Issues and Research in Respiratory Failure from Severe Acute Respiratory Syndrome Am. J. Respir. Crit. Care Med., March 1, 2005; 171(5): 518 - 526. [Abstract] [Full Text] [PDF]

				A. J. Verheul, C. B. Mantilla, W.-Z. Zhan, M. Bernal, P. N. R. Dekhuijzen, and G. C. Sieck Influence of corticosteroids on myonuclear domain size in the rat diaphragm muscle J Appl Physiol, November 1, 2004; 97(5): 1715 - 1722. [Abstract] [Full Text] [PDF]

				C. N. Sessler Train-of-Four To Monitor Neuromuscular Blockade? Chest, October 1, 2004; 126(4): 1018 - 1022. [Full Text] [PDF]

				M. H. Baumann, B. W. McAlpin, K. Brown, P. Patel, I. Ahmad, R. Stewart, and M. Petrini A Prospective Randomized Comparison of Train-of-Four Monitoring and Clinical Assessment During Continuous ICU Cisatracurium Paralysis Chest, October 1, 2004; 126(4): 1267 - 1273. [Abstract] [Full Text] [PDF]

				G. J. Rodrigo, C. Rodrigo, and J. B. Hall Acute Asthma in Adults: A Review Chest, March 1, 2004; 125(3): 1081 - 1102. [Abstract] [Full Text] [PDF]

				S. Deem, C. M. Lee, and J. R. Curtis Acquired Neuromuscular Disorders in the Intensive Care Unit Am. J. Respir. Crit. Care Med., October 1, 2003; 168(7): 735 - 739. [Full Text] [PDF]

				E. R. McFadden Jr. Acute Severe Asthma Am. J. Respir. Crit. Care Med., October 1, 2003; 168(7): 740 - 759. [Abstract] [Full Text] [PDF]

				G. Z. Racz, G. Gayan-Ramirez, D. Testelmans, P. Cadot, K. De Paepe, E. Zador, F. Wuytack, and M. Decramer Early Changes in Rat Diaphragm Biology with Mechanical Ventilation Am. J. Respir. Crit. Care Med., August 1, 2003; 168(3): 297 - 304. [Abstract] [Full Text] [PDF]

				F. Laghi and M. J. Tobin Disorders of the Respiratory Muscles Am. J. Respir. Crit. Care Med., July 1, 2003; 168(1): 10 - 48. [Abstract] [Full Text] [PDF]

				S. Nava From the Author Eur. Respir. J., February 1, 2003; 21(2): 378 - 378. [Full Text] [PDF]

				P Phipps and C S Garrard The pulmonary physician in critical care * 12: Acute severe asthma in the intensive care unit Thorax, January 1, 2003; 58(1): 81 - 88. [Abstract] [Full Text] [PDF]

				B. De Jonghe, T. Sharshar, J.-P. Lefaucheur, F.-J. Authier, I. Durand-Zaleski, M. Boussarsar, C. Cerf, E. Renaud, F. Mesrati, J. Carlet, et al. Paresis Acquired in the Intensive Care Unit: A Prospective Multicenter Study JAMA, December 11, 2002; 288(22): 2859 - 2867. [Abstract] [Full Text] [PDF]

				B. Gehlbach, J. P. Kress, J. Kahn, C. DeRuiter, A. Pohlman, and J. Hall Correlates of Prolonged Hospitalization in Inner-city ICU Patients Receiving Noninvasive and Invasive Positive Pressure Ventilation for Status Asthmaticus Chest, November 1, 2002; 122(5): 1709 - 1714. [Abstract] [Full Text] [PDF]

				S. Nava, C. Fracchia, G. Callegari, N. Ambrosino, N. Barbarito, and G. Felicetti Weakness of respiratory and skeletal muscles after a short course of steroids in patients with acute lung rejection Eur. Respir. J., August 1, 2002; 20(2): 497 - 499. [Abstract] [Full Text] [PDF]

				B Tabarki, A Coffinieres, P Van den Bergh, G Huault, P Landrieu, and G Sebire Critical illness neuromuscular disease: clinical, electrophysiological, and prognostic aspects Arch. Dis. Child., February 1, 2002; 86(2): 103 - 107. [Abstract] [Full Text] [PDF]

				J. M. Shapiro Intensive Care Management of Status Asthmaticus Chest, November 1, 2001; 120(5): 1439 - 1441. [Full Text] [PDF]

				M. I. Polkey and J. Moxham Clinical Aspects of Respiratory Muscle Dysfunction in the Critically Ill Chest, March 1, 2001; 119(3): 926 - 939. [Full Text] [PDF]

				M. A. JANTZ and S. A. SAHN Corticosteroids in Acute Respiratory Failure Am. J. Respir. Crit. Care Med., October 1, 1999; 160(4): 1079 - 1100. [Full Text]

				M. H. Kollef Improving Outcomes in the ICU Setting : Are We Effectively Using all of the Information That Is Potentially Available to Us? Chest, June 1, 1999; 115(6): 1490 - 1492. [Full Text] [PDF]

				N. Awadh Behbehani, F. Al-Mane, Y. D'yachkova, P. Pare, and J. M. FitzGerald Myopathy Following Mechanical Ventilation for Acute Severe Asthma: The Role of Muscle Relaxants and Corticosteroids Chest, June 1, 1999; 115(6): 1627 - 1631. [Abstract] [Full Text] [PDF]

				G. GAYAN-RAMIREZ, F. VANDERHOYDONC, G. VERHOEVEN, and M. DECRAMER Acute Treatment with Corticosteroids Decreases IGF-1 and IGF-2 Expression in the Rat Diaphragm and Gastrocnemius Am. J. Respir. Crit. Care Med., January 1, 1999; 159(1): 283 - 289. [Abstract] [Full Text]